Pot Stock Alert: This Company Has the Biggest Upside in 2020

Green Organic Dutchman Holdings Ltd (TSX:TGOD) has huge upside in 2020. Just be careful to note the inherent risks. If you want to get huge cannabis upside, this is your stock.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Cannabis stocks have been in a world of pain this year. Nearly every pot stock has been hit hard, with some losing as much as 90% of their value. Once a billion-dollar company, Green Organic Dutchman Holdings (TSX:TGOD) is now valued at just $250 million. In 2020, however, sales could surge to historic levels. And judging by recent data, the cannabis boom is far from over.

This is perhaps the riskiest stock in the industry today. Yet in exchange for that risk, investors get a once-in-a-lifetime opportunity for massive gains. If the company can execute its growth plan, the stock could easily double next year. If the pot market experiences an industry-wide resurgence, the upside could be even higher.

You’ll want to keep this position small given the associated risks, but this lottery ticket might be worth the cost.

Going it alone

Green Organic used to be on top of the cannabis world. Last year, Aurora Cannabis (TSX:ACB)(NYSE:ACB), which was worth $10 billion at the time, purchased nearly one-fifth of the company. Just as importantly, it committed to buying 20% of Green Organic’s output.

In a single deal, Green Organic secured a leading cannabis partner and a cornerstone customer. It was a big vote of confidence in an industry rife with concern. Aurora also agreed to help scale Green Organic’s grow facilities using its world-class consulting arm.

At the time, it seemed as if Green Organic could do no wrong. This year, that all changed after Aurora decided to sell its entire stake (apart from some warrants) while canceling its commitment to purchase 20% of Green Organic’s production.

Today, Green Organic is stuck upstream without a paddle. First production is coming online, and it has zero long-term partners or large customers lined up, at least not anything close to the size of Aurora. It truly is operating as an independent cannabis company.

That’s a dangerous move considering cannabis output is increasingly commoditized, and competitors without the expertise or funding necessary to create in-demand brands will suffer pricing erosion.

With all this bad news, it’s no wonder why TGOD stock has led the cannabis market lower. But if you look closely, there could be a turnaround in the works.

Staging a turnaround

It’s not all bad. As management has noted, Aurora’s purchasing commitment was at wholesale prices. After the deal was canceled, Green Organic is now clear to sell that production at retail prices, increasing the potential for revenue and profit. Of course, the company still needs to prove that it can sell its production at any price.

This year, sales will only total roughly US$12 million. However, two grow facilities are expected to come online at the end of 2019, causing analysts to forecast US$89 million in sales next year. That means the company sells at less than three times earnings. For comparison, Aurora trades at more than double the valuation.

In 2020, if Green Organic can prove that its organic production can successfully sell on the open market, expect that valuation gap to close quickly. No one is sure if this is possible, but that’s why you’re getting a fantastic price. The market is clearly betting against this scenario, but if the Green Organic can move its product in volume, you could earn a 100% return in less than 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »